Table 1:
WMV (mL) | GMV (mL) | CSFV (mL) | NV (mL) | BPV (mL) | ICV (mL) | |
---|---|---|---|---|---|---|
Contr1 | 581 ± 67 | 639 ± 58 | 156 ± 45 | 28 ± 7 | 1247 ± 119 | 1404 ± 119 |
Contr2 | 581 ± 69 | 637 ± 53 | 156 ± 47 | 31 ± 12 | 1250 ± 119 | 1406 ± 120 |
MS1 | 452 ± 88 | 617 ± 48 | 247 ± 60 | 52 ± 22 | 1122 ± 99 | 1369 ± 99 |
MS2 | 464 ± 109 | 600 ± 47 | 231 ± 60 | 60 ± 21 | 1124 ± 98 | 1355 ± 97 |
Diff Contr1-Contr2 | 0 ± 11 | −1 ± 13 | 0 ± 4 | 4 ± 12 | 2 ± 6 | 2 ± 7 |
Diff MS1-MS2 | 12 ± 37 | −17 ± 40 | −16 ± 7c | 8 ± 11b | 2 ± 9 | −13 ± 8c |
Diff Contr1-MS1 | −129 ± 104c | −22 ± 68 | 91 ± 71c | 24 ± 18c | −126 ± 133c | −35 ± 117 |
Diff Contr2-MS2 | −117 ± 113c | −37 ± 67b | 75 ± 70c | 29 ± 17c | −126 ± 136c | −50 ± 116 |
Note:—Diff indicates difference; Contr, control group; MS, MS patient group; 1, measurement 1; 2, measurement 2.
For each tissue volume, the mean value and SD are given. The mean difference and SD of the first measurement and the second measurement and between controls and patients with MS are also provided. The MS group received Gd in the second measurement.
P < .05 (significant difference).
P < .005 (significant difference).